Jefferies is cautious about Lance as the firm thinks that the company's DSD work could result in continued dislocation. The firm set a $26 target on the stock. :theflyonthewall.com
News For LNCE From The Last 14 Days
Check below for free stories on LNCE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
